Company Overview of Depomed, Inc.
John Joseph DeLucca
Director Nominee, Depomed, Inc.
|Age||Total Calculated Compensation||This person is connected to 6 Board Members in 6 different organizations across 13 different industries.|
See Board Relationships
7999 Gateway BoulevardPhone: 510-744-8000
Newark, California 94560
Board Members Memberships
Vice Chair of Board of Trustees
Director, Chairman of Audit Committee and Member of Compensation Committee
Independent Director, Member of Audit Committee, Member of Nominating Committee and Member of Compensation Committee
Fairleigh Dickinson University
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Ron Cohen M.D.||Founder, Chief Executive Officer, President and Director|
Acorda Therapeutics, Inc.
|Steven M. Klosk||Chief Executive Officer, President and Director|
|William S. Marth||Chief Executive Officer, President and Director|
Albany Molecular Research Inc.
|Arthur P. Bedrosian J.D.||Chief Executive Officer, Director and Chairman of Strategic Planning Committee|
Lannett Company, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Pricing Committee and Member of Strategic Operations Committee|
Emergent BioSolutions, Inc.
|$1.4M||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.